Lubiprostone OverviewLubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. It was initially approved by the U.S. Food and Drug Administration (FDA) in 2006 and recommended for use in the UK by the National Institute for Health and Care Excellence (NICE) in 2014. It is expensive as of 2017, with the c...
Read more Lubiprostone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amitiza
Recent Lubiprostone Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 24mcg, 24ugm, 8mcg, 8ugm